SCA
NARI

Snowden Capital Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Snowden Capital Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,417
Closed -$225K – 1267
2024
Q4 		$225K Buy
+4,417
New +$217K 0.01% 1111
2024
Q3 		– Sell
-4,711
Closed -$227K – 1265
2024
Q2 		$227K Sell
4,711
-107
-2% -$4.74K 0.01% 1090
2024
Q1 		$231K Sell
4,818
-167
-3% -$8.92K 0.01% 1075
2023
Q4 		$324K Sell
4,985
-54
-1% -$3.25K 0.01% 887
2023
Q3 		$330K Buy
5,039
+1,574
+45% +$99K 0.01% 826
2023
Q2 		$201K Buy
3,465
+34
+1% +$2.15K 0.01% 1105
2023
Q1 		$212K Buy
3,431
+84
+3% +$5.04K 0.01% 1060
2022
Q4 		$213K Buy
3,347
+253
+8% +$18.3K 0.01% 1044
2022
Q3 		$224K Buy
+3,094
New +$230K 0.01% 995

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Snowden Capital Advisors's NARI Position: Q1 2025 in Review

Snowden Capital Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 4,417 shares — an estimated $225K sold.

Snowden Capital Advisors first reported a position in NARI in Q3 2022 and held it in 9 quarters. The position peaked at $330K in Q3 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Snowden Capital Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Snowden Capital Advisors sold 4,417 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $225K.
  • Snowden Capital Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 9 quarters.
  • Snowden Capital Advisors's Inari Medical, Inc. Common Stock position peaked at $330K in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Snowden Capital Advisors's 13F filing for Q1 2025, filed 14 May 2025.